Intibios
- Company typePrivate
- Founded2020
- HeadquartersPetukangan Utara, Indonesia
- Headcount101–250
- GTM typeB2C
- OfferingServices
What Intibios does
Intibios (legal entity PT Inti Bios Persada Sejahtera) is an Indonesian private healthcare company founded in 2020 as a COVID-19 PCR/antigen testing provider, which subsequently expanded into a fully integrated network of clinic, laboratory, and pharmacy services. The company operates 10 owned branches across major Indonesian cities — Jakarta (PIK, Hang Tuah, Ciputat), Bandung, Karawang, Cirebon, Semarang, Yogyakarta, Surabaya, Denpasar/Bali, and Banjarmasin — with its head office in South Jakarta. Its service portfolio spans over 100 clinical laboratory tests (hematology, biochemistry, immunology, PCR, cardiovascular, hepatitis, lipid profiles), radiology imaging (USG, X-Ray, mammography, automated breast ultrasound), clinic consultations (general practice, dental, physiotherapy, vaccinations), pharmacy dispensary, and Medical Check-Up (MCU) packages. Additional offerings include home and office care (mobile sample collection, on-site vaccinations), pre-marital vaccination packages (HPV, MMR, Hepatitis B), and GARUDA-certified maritime MCU services at the Bandung branch.
The business model is service-based and operates across two GTM motions: (1) walk-in B2C volume through the 10 retail branches and WhatsApp-driven booking, and (2) B2B corporate MCU programs (e.g., the 2,174-employee program for Sarana Menara Nusantara Group executed across all 10 branches in June 2024). Customer segments include individual consumers, corporate enterprises, pre-marital couples, seafarers, and homebound/office-based patients. Distribution is augmented through promotional partnerships with BINUS University (up to 20% member discount) and Alfagift (up to 30% member discount). Pricing is not publicly disclosed on the website. The company has 101-250 employees, no disclosed external funding rounds, no parent company, and is privately held with no stock exchange listing.
Intibios firmographics
Firmographics- Name
- Intibios
- Legal name
- PT Inti Bios Persada Sejahtera
- Website
- https://intibios.co.id
- Company type
- Private
- Founded year
- 2020
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Ownership category
- akta.pro rank
Intibios industry classification
Industry- Product category
- Medical Laboratory & Diagnostic Services
- NAICS
- Medical Laboratories (621511)
- SIC
- Services-Medical Laboratories (8071)
- akta.pro primary industry
- Central Laboratory Services (Core Lab Operations) (HLAGAEAA)
Keywords
Where Intibios is headquartered
LocationHeadquarters
- HQ city
- Petukangan Utara
- HQ country
- Indonesia
- HQ region
- Asia
Offices12 records
Markets served
Intibios business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Supply Chain, Infrastructure, Marketing or Sales
Revenue model
- Clinical Consultation and Medical Services: Revenue generated from doctor consultations, medical examinations, physiotherapy, scoliosis treatment, dental care, and injectable vitamin services at clinic locations.
- Laboratory Diagnostic Services: Revenue from over 100 types of clinical laboratory tests including hematology, biochemistry, immunology, PCR, cardiovascular panels, hepatitis screening, lipid profiles, and urinalysis.
- Medical Check-Up (MCU) Packages: Revenue from bundled health evaluation packages including Personal MCU, Prospective Employee MCU, Employee MCU, and VIP MCU packages. Corporate MCU programs (e.g., Sarana Menara Nusantara Group with 2,174 participants across 10 branches) represent a significant revenue stream.
- Pharmacy / Retail Drug Sales: Revenue from OTC (over-the-counter) and ethical (prescription) medication dispensary at pharmacy branches.
- Vaccination Services: Revenue from pre-marital vaccination packages (HPV, MMR, Hepatitis B), Typhoid and Hepatitis A combined vaccines, and general immunizations offered across all branches.
- Home and Office Care: Revenue from on-site services including swab antigen/PCR testing, sample collection, vitamin injections, and vaccinations delivered at patient homes or workplaces.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Pay-as-you-go | BINUS Member Discount |
| Other | Pay-as-you-go | Alfagift Member Discount |
| Unit Pricing | Pay-as-you-go | Medical Check-Up Packages |
| Unit Pricing | Pay-as-you-go | Pre-Marital Vaccination Packages |
| Unit Pricing | Pay-as-you-go | Laboratory and Clinic Services |
Go-to-market motion1 record
Distribution channels4 records
Marketing channels6 records
Intibios product offering
Product offeringCore offering
Intibios operates an integrated medical laboratory, clinic, and pharmacy network across 10 strategic locations in Indonesia. The company offers over 100 types of clinical laboratory tests, radiology imaging, doctor consultations, vaccinations, pharmacy dispensary, comprehensive Medical Check-Up (MCU) packages, home and office care services, and supporting diagnostic services such as EKG, treadmill, audiometry, and spirometry.
Product overview
Intibios Lab, Klinik & Farmasi is a unified healthcare network offering integrated laboratory, clinic, and pharmacy services across 10 strategic locations in Indonesia. The core offering consists of diagnostic laboratory testing (over 100 clinical tests including hematology, immunology, PCR, and biochemistry), clinic consultations with medical examinations and vaccinations, advanced radiology imaging, and pharmacy services. The platform is complemented by specialized services including Medical Check Up packages, medical support diagnostics (EKG, Treadmill, Audiometry, Spirometry), home/office care, dental care, and pre-marital vaccination programs. Originally established in 2020 to provide PCR and antigen COVID-19 testing, the company has expanded into a comprehensive healthcare network.
Differentiator
Problem solved
Functional benefit
Quantifiable outcome
- 2174 employees screened in a single corporate MCU program for Sarana Menara Nusantara Group across 10 branches
- +1 more outcomes
Companies that use Intibios
Customer profileNamed customers4 records
Segments5 records
Ideal customer profiles4 records
Intibios technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
Intibios partnerships and signals
Strategic signalPartnerships
Two partnerships are on record, tiered minor.
- BINUS UniversityminorBINUS University members receive up to 20% discount on Intibios services by presenting a valid BINUS member card. This partnership extends Intibios' reach to BINUS' student and staff community, offering discounted health services as a membership benefit.
- AlfagiftminorAlfagift members receive up to 30% discount on Intibios services by showing their physical or electronic Alfagift member card. This promotional partnership leverages the Alfagift platform's user base to drive customer acquisition for Intibios.
Scale indicators5 records
Recent moves7 records
Expansion highlights6 records
Intibios competitors and assessment
Company assessmentDirect peers
- Prodia: Indonesia's largest clinical laboratory network with 150+ branches offering a comparable menu of hematology, immunology, PCR, and MCU services. Prodia is the dominant direct peer for Intibios's core diagnostic lab business.
- Medika Plaza: Integrated outpatient healthcare provider combining clinic, lab, and pharmacy services in Indonesia, with a similar one-stop operating model to Intibios.
- Biotest Indonesia: Mid-sized Indonesian clinical laboratory network providing diagnostic testing, MCU services, and home visit sample collection — a direct peer in the same mid-tier outpatient lab segment.
- Pramita: Established Indonesian clinical laboratory chain with a similar focus on outpatient diagnostics, MCU packages, and corporate health screening. Directly competes with Intibios in Java's mid-tier cities.
- Kimia Farma Diagnostika: Diagnostics arm of state-owned pharmacy chain Kimia Farma, operating clinic-and-lab-integrated branches across Indonesia. Closely comparable to Intibios's pharmacy + lab + clinic co-location model.
- Pathlab Indonesia: Clinical laboratory provider offering routine and specialized diagnostic tests plus MCU services to walk-in patients and corporate clients in Indonesia.
Broad incumbents
- Omni Hospitals: Private hospital group operating across major Indonesian cities with outpatient lab, radiology, and MCU packages — competing with Intibios in the corporate and executive health screening segments.
- Brawijaya Healthcare Group: Indonesian hospital and outpatient healthcare group with integrated lab and MCU offerings. Comparable as a broader healthcare provider with overlapping diagnostic service lines.
- Mitra Keluarga Karyasehat: Major Indonesian private hospital chain with attached outpatient diagnostics and MCU capabilities. Broad incumbent competing for premium-tier preventive screening and corporate health contracts.
- Siloam Hospitals: Indonesia's largest private hospital group with in-house laboratory, radiology, and outpatient services. A broad incumbent that competes for corporate MCU and outpatient diagnostics demand from a larger, hospital-anchored platform.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks7 records
Key highlights7 records
Customer concentration
Intibios social profiles
Digital presenceIntibios financial estimates
Financial estimateRevenue estimate
Valuation estimate
Intibios leadership team
Management profileNumber of profiles
Intibios funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Intibios M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Intibios
What does Intibios do?
Intibios operates an integrated medical laboratory, clinic, and pharmacy network across 10 strategic locations in Indonesia. The company offers over 100 types of clinical laboratory tests, radiology imaging, doctor consultations, vaccinations, pharmacy dispensary, comprehensive Medical Check-Up (MCU) packages, home and office care services, and supporting diagnostic services such as EKG, treadmill, audiometry, and spirometry.
Is Intibios a public or private company?
Intibios is a private company. It is classified as unknown and is currently operating.
When was Intibios founded?
Intibios was founded in 2020. It employs 101 to 250 people.
Where is Intibios based?
Intibios is headquartered in Petukangan Utara, Indonesia, in the Asia region.
How does Intibios make money?
Six revenue lines are on record. Clinical Consultation and Medical Services are the primary driver. The others are laboratory Diagnostic Services, medical Check-Up (MCU) Packages, pharmacy / Retail Drug Sales, vaccination Services and home and Office Care.
Who are Intibios's main competitors?
Direct peers on record are Prodia, Medika Plaza, Biotest Indonesia, Pramita, Kimia Farma Diagnostika and Pathlab Indonesia. Broad incumbents are Omni Hospitals, Brawijaya Healthcare Group, Mitra Keluarga Karyasehat and Siloam Hospitals.
Does Intibios have an API?
No public API is recorded for Intibios.
What industry is Intibios in?
Intibios's product category is Medical Laboratory & Diagnostic Services. Its primary akta.pro industry code is HLAGAEAA, Central Laboratory Services (Core Lab Operations). Its NAICS code is 621511 and its SIC code is 8071.